According to Swedish Orphan Biovitrum's latest financial reports the company's current EPS (TTM) is HK$5.42. In 2022 the company made an earnings per share (EPS) of HK$5.23 a decrease over its 2021 EPS that were of HK$7.76.
Year | EPS | Change |
---|---|---|
2023 (TTM) | HK$5.47 | 4.74% |
2022 | HK$5.23 | -32.67% |
2021 | HK$7.76 | -16.9% |
2020 | HK$9.34 | 2.54% |
2019 | HK$9.11 | 19.37% |
2018 | HK$7.63 | 98.42% |
2017 | HK$3.85 | 41.84% |
2016 | HK$2.71 | 1227.12% |
2015 | HK$0.20 | -117.81% |
2014 | -HK$1.15 | 184.25% |
2013 | -HK$0.40 | -12.81% |
2012 | -HK$0.46 | -433.93% |
2011 | HK$0.14 | -126.14% |
2010 | -HK$0.53 | -258.4% |
2009 | HK$0.33 |